These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tapentadol immediate release for the relief of moderate-to-severe acute pain. Hartrick CT Expert Opin Pharmacother; 2009 Nov; 10(16):2687-96. PubMed ID: 19795998 [TBL] [Abstract][Full Text] [Related]
4. Single dose analgesic efficacy of tapentadol in postsurgical dental pain: the results of a randomized, double-blind, placebo-controlled study. Kleinert R; Lange C; Steup A; Black P; Goldberg J; Desjardins P Anesth Analg; 2008 Dec; 107(6):2048-55. PubMed ID: 19020157 [TBL] [Abstract][Full Text] [Related]
6. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution? Candiotti KA; Gitlin MC Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361 [TBL] [Abstract][Full Text] [Related]
7. Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single molecule. Tzschentke TM; Jahnel U; Kogel B; Christoph T; Englberger W; De Vry J; Schiene K; Okamoto A; Upmalis D; Weber H; Lange C; Stegmann JU; Kleinert R Drugs Today (Barc); 2009 Jul; 45(7):483-96. PubMed ID: 19834626 [TBL] [Abstract][Full Text] [Related]
8. Tapentadol immediate release: a review of its use in the treatment of moderate to severe acute pain. Frampton JE Drugs; 2010 Sep; 70(13):1719-43. PubMed ID: 20731478 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study. Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of tapentadol ER for managing moderate to severe chronic pain. Afilalo M; Morlion B Pain Physician; 2013 Jan; 16(1):27-40. PubMed ID: 23340531 [TBL] [Abstract][Full Text] [Related]
14. Tapentadol a 'realistic alternative' to strong opioids for severe pain. Pinn S Br J Hosp Med (Lond); 2008 Sep; 69(9):499. PubMed ID: 18819294 [No Abstract] [Full Text] [Related]
15. Tapentadol - A representative of a new class of MOR-NRI analgesics. Zajączkowska R; Przewłocka B; Kocot-Kępska M; Mika J; Leppert W; Wordliczek J Pharmacol Rep; 2018 Aug; 70(4):812-820. PubMed ID: 29921501 [TBL] [Abstract][Full Text] [Related]
16. Advances in perioperative pain management: use of medications with dual analgesic mechanisms, tramadol & tapentadol. Nossaman VE; Ramadhyani U; Kadowitz PJ; Nossaman BD Anesthesiol Clin; 2010 Dec; 28(4):647-66. PubMed ID: 21074743 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain. Kwong WJ; Ozer-Stillman I; Miller JD; Haber NA; Russell MW; Kavanagh S Clin Ther; 2010 Sep; 32(10):1768-81. PubMed ID: 21194601 [TBL] [Abstract][Full Text] [Related]
18. Unique pharmacology of tapentadol for treating acute and chronic pain. Knezevic NN; Tverdohleb T; Knezevic I; Candido KD Expert Opin Drug Metab Toxicol; 2015; 11(9):1475-92. PubMed ID: 26215077 [TBL] [Abstract][Full Text] [Related]
19. Tapentadol (Palexia) for moderate to severe acute pain. Drug Ther Bull; 2012 Mar; 50(3):30-3. PubMed ID: 22419754 [TBL] [Abstract][Full Text] [Related]
20. Tapentadol for pain: a treatment evaluation. Hartrick CT; Rodríguez Hernandez JR Expert Opin Pharmacother; 2012 Feb; 13(2):283-6. PubMed ID: 22192161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]